Enhancements in key models power HT-PBPK simulations and AI-driven drug design with unprecedented performance and accuracy
Simulations Plus, Inc, a leading provider of biosimulation, simulation-enabled...
Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies
Certara, Inc., a global leader in biosimulation, announced the...
VeriSIM Life announces recognition for continued advances with BIOiSIM, a first-in-class virtual drug development engine.
VeriSIM Life— the leading artificial intelligence (AI)-enabled, unique R&D decisions...